Cure My Disease

Don't miss your cure!

 Log in / Sign up

Thinner needle for thyroid biopsy may reduce pain without sacrificing accuracy

NCT ID NCT07683039

Symptom relief Sponsor: Izmir Ataturk Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study compares two needle sizes (21-gauge vs 27-gauge) used for ultrasound-guided fine needle biopsy of thyroid nodules. The goal is to see which size causes less pain and discomfort during the procedure while still collecting enough cells for diagnosis. Adults with thyroid nodules needing biopsy are randomly assigned to one needle size, and pain is measured right after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If one needle size causes less pain without affecting sample quality, it could become the preferred choice for thyroid biopsies, improving patient comfort.
What could go wrong
This is a small, single-hospital study. Results may not apply to all patients or settings, and the smaller needle might yield fewer adequate samples.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

159 people

The number who actually took part.

Started

Jan 2024

Finished

Mar 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 88 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Thyroid nodules requiring ultrasound-guided FNB with a maximum diameter ≥10 mm, * Intraglandular nodules with relatively central location within the thyroid gland Exclusion Criteria: * Patient refusal to provide informed consent, * History of bleeding tendency or use of anticoagulant medication, * Substernal or subclavicular localization of the lesion in cases of large goiter.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Thyroid nodular disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nodular goiter

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Thyroid nodular disease

Contacts and locations

Locations

  • İzmir Atatürk Training and Education Hospital

    Izmir, 35620, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.